Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Tacrolimus prolonged release capsules (Advagraf)	TA85 - Immunosuppressive therapy for renal transplantation in adults	New post-transplant
Tacrolimus prolonged release capsules (Advagraf)	TA85 - Immunosuppressive therapy for renal transplantation in adults	Post-transplant pre 2015
Tacrolimus		Specialist use only in neurological conditions
Tadalafil 10mg	TA273 - Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)	High relative cost. In line with SLS criteria. Four tab per month - on demand. Non-formulary for LUTS in BPS.
Tafluprost (preservative free) 15 micrograms/ml (Saflutan)		Specialist ophthalmologist recommendation. Second line preservative free option. For use within license for those patients requiring a preservative free preparation.
Taurolock		Hospital use only
Taurolock Hep 500		Hospital use only
Temazepam tablets		Tablets - extremely high relative cost.
Temoporfin injection		National CDF list
Temsirolimus infusion (Torisel®)	TA207 - Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal) (Negative TA) TA178 - Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (Negative TA)	Hospital use only

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.